NK cell Signaling

Natural killer (NK) cells are cytotoxic cells of the innate immune system that respond to foreign or host cells displaying stress signals. NK cell activity is controlled by engagement of various cell surface receptors that induce activation or inhibitory pathways, the balance of which determines the cell’s phenotype. Find the latest research on NK cell signaling here.

September 9, 2020
Open Access

In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age

PLoS Biology
Nicole A P LiebermanAlexander L Greninger
August 24, 2020
Open Access

Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome

Journal of Clinical Immunology
Lila BouadmaYves Lévy
September 15, 2020
Open Access

Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells

Frontiers in Immunology
Chen ZhuMarielle Chiron
August 10, 2020

Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia

Clinical Lymphoma, Myeloma & Leukemia
Hiroshi UreshinoShinya Kimura
September 18, 2020

Rps27a might act as a controller of microglia activation in triggering neurodegenerative diseases

PloS One
Nasibeh KhayerMaryam Jalessi
August 11, 2020
Case Report
Open Access

X-Linked Lymphoproliferative Disease in Latvia: A Report of Two Clinically Distinct Cases

Case Reports in Medicine
Ieva NokalnaLinda Gailite
August 15, 2020

Natural killer cell impairment in ovarian clear cell carcinoma

Journal of Leukocyte Biology
Ornella PatriziGiovanna Tabellini
August 12, 2020
Open Access

Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells

BioRxiv : the Preprint Server for Biology
M. T. MaDongfang Liu
July 23, 2020
Open Access

Lymph node involvement by enteropathy-like indolent NK-cell proliferation

Virchows Archiv : an International Journal of Pathology
Jean-Louis DargentLaurence de Leval
September 16, 2020
Open Access

Immunomodulation in pomalidomide, dexamethasone, and daratumumab -treated relapsed/refractory multiple myeloma patients

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
William E PierceallAnjan Thakurta
September 17, 2020

HSV-TK Expressing Mesenchymal Stem Cells Exert Inhibitory Effect on Cervical Cancer Model

International Journal of Molecular and Cellular Medicine
Azra KenarkoohiShahab Falahi
July 23, 2020
Open Access

Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells

Molecular Therapy. Methods & Clinical Development
Jian GaoAnja Ehrhardt
July 28, 2020
Open Access

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy

Frontiers in Immunology
Cai Zhang, Yuxia Liu
August 18, 2020
Open Access

NK cells and ILCs in tumor immunotherapy

Molecular Aspects of Medicine
Simona SivoriLorenzo Moretta
July 14, 2020
Open Access

ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome

Frontiers in Oncology
Nicholas J W EasomRamou Njie
July 17, 2020
Open Access

Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis

BioRxiv : the Preprint Server for Biology
L. DucimetiereSonia Tugues
August 10, 2020
Open Access

Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas

Scientific Reports
Bassel DawodJun Wang
July 17, 2020
Open Access

The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing

BioRxiv : the Preprint Server for Biology
E. SeidelOfer Mandelboim

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2020 Meta ULC. All rights reserved